🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Stifel raises TransUnion stock target on stable market trends

EditorNatashya Angelica
Published 10/24/2024, 08:05 PM
Updated 10/24/2024, 08:06 PM
TRU
-

On Thursday, Stifel updated its financial outlook on TransUnion (NYSE:TRU) shares, increasing the price target to $120 from the previous $103, while maintaining a Buy rating on the shares. The firm's analyst cited stable market trends as a significant factor for the raised target.

The analyst's statement highlighted that TransUnion has navigated through challenging comparisons, including declines in credit and mortgage volumes. These conditions are now seen as a setup for potential growth for the company as it moves into 2025.

Stifel's revised price target represents a 6.5x turn EV/EBITDA discount compared to the Info Services industry peers, excluding TransUnion itself. This adjustment reflects a more optimistic view of the company's valuation and its future performance in the market.

The firm's decision to maintain a Buy rating alongside the price target increase suggests confidence in TransUnion's ability to capitalize on the current market conditions. The company's performance against tough comparisons has been noted as a positive indicator of its potential growth trajectory.

TransUnion's stock price is expected to be influenced by this updated financial analysis, as investors and stakeholders consider Stifel's revised estimates and the underlying reasons for the optimistic outlook. The new price target is set with an expectation of improved growth for TransUnion as it progresses into the next fiscal year.

In other recent news, TransUnion has been making significant strides in its financial performance. The company reported a robust 12% increase in Q3 revenue, notably a 17% growth in U.S. financial services. This exceeded expectations and led to an upward revision of its full-year guidance. The earnings per share also improved by 14% to $1.04, with the full-year earnings per share projected at $3.87 to $3.93.

Baird, an independent financial service firm, has shown confidence in TransUnion's growth prospects, raising the company's price target to $130 from the previous $104. The firm maintained its Outperform rating on the credit reporting agency, highlighting the company's potential for strong multi-year growth due to factors such as improving macroeconomic environment and specific attributes of TransUnion's business performance.

TransUnion's transformation program, expected to yield $200 million in free cash flow benefits by 2026, is another key development. The company's capital expenditures are projected to decrease to 8% of revenues for 2024 and 2025, contributing to margin expansion.

Despite a slowdown in the mortgage segment and consumer lending growth rates in India, these recent developments underline TransUnion's strategic direction and commitment to delivering value to its customers and shareholders.

InvestingPro Insights

TransUnion's recent performance aligns with Stifel's optimistic outlook. According to InvestingPro data, the company's revenue growth has been robust, with a 12.01% increase in the most recent quarter. This growth trajectory supports the analyst's view of TransUnion's potential as it moves into 2025.

InvestingPro Tips highlight that TransUnion has impressive gross profit margins, which stood at 59.96% over the last twelve months. This strong profitability metric underscores the company's operational efficiency and may contribute to its ability to navigate challenging market conditions.

Moreover, TransUnion's stock has shown remarkable performance, with a 119.71% total return over the past year. This significant price appreciation reflects investor confidence in the company's strategy and market position, further supporting Stifel's Buy rating and increased price target.

For investors seeking a more comprehensive analysis, InvestingPro offers 17 additional tips for TransUnion, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.